

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 5.44995181 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.36210742 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 5.36210742 |
| 4 | protein retention in ER lumen (GO:0006621) | 5.34466639 |
| 5 | NADH metabolic process (GO:0006734) | 5.22573988 |
| 6 | proline biosynthetic process (GO:0006561) | 5.20694922 |
| 7 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.17049036 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.97325225 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 4.97325225 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.66079556 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 4.66079556 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 4.34095293 |
| 13 | protein maturation by protein folding (GO:0022417) | 4.28383005 |
| 14 | proline metabolic process (GO:0006560) | 4.08732921 |
| 15 | very long-chain fatty acid metabolic process (GO:0000038) | 4.08302693 |
| 16 | GDP-mannose metabolic process (GO:0019673) | 3.97904271 |
| 17 | low-density lipoprotein particle clearance (GO:0034383) | 3.93369372 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 3.92698033 |
| 19 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.91625166 |
| 20 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.88873928 |
| 21 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.82468883 |
| 22 | 4-hydroxyproline metabolic process (GO:0019471) | 3.78599682 |
| 23 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.67511250 |
| 24 | oxaloacetate metabolic process (GO:0006107) | 3.65180210 |
| 25 | basement membrane organization (GO:0071711) | 3.61012880 |
| 26 | gluconeogenesis (GO:0006094) | 3.59308220 |
| 27 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.58415456 |
| 28 | ethanol oxidation (GO:0006069) | 3.57636123 |
| 29 | glucose 6-phosphate metabolic process (GO:0051156) | 3.57121740 |
| 30 | heme transport (GO:0015886) | 3.56466712 |
| 31 | regulation of cholesterol metabolic process (GO:0090181) | 3.56148268 |
| 32 | monosaccharide biosynthetic process (GO:0046364) | 3.47178289 |
| 33 | thioester biosynthetic process (GO:0035384) | 3.47022466 |
| 34 | acyl-CoA biosynthetic process (GO:0071616) | 3.47022466 |
| 35 | urea cycle (GO:0000050) | 3.44453623 |
| 36 | axon ensheathment in central nervous system (GO:0032291) | 3.44076052 |
| 37 | central nervous system myelination (GO:0022010) | 3.44076052 |
| 38 | hexose biosynthetic process (GO:0019319) | 3.40769114 |
| 39 | glyoxylate metabolic process (GO:0046487) | 3.34260093 |
| 40 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.33816317 |
| 41 | sulfur amino acid catabolic process (GO:0000098) | 3.33514094 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.32107457 |
| 43 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.30934066 |
| 44 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.29597805 |
| 45 | bile acid biosynthetic process (GO:0006699) | 3.28287205 |
| 46 | ethanol metabolic process (GO:0006067) | 3.26066008 |
| 47 | reverse cholesterol transport (GO:0043691) | 3.24664904 |
| 48 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.23232455 |
| 49 | amyloid precursor protein catabolic process (GO:0042987) | 3.21088922 |
| 50 | myelin maintenance (GO:0043217) | 3.20261359 |
| 51 | tricarboxylic acid metabolic process (GO:0072350) | 3.20055465 |
| 52 | urea metabolic process (GO:0019627) | 3.19878832 |
| 53 | amyloid precursor protein metabolic process (GO:0042982) | 3.19360990 |
| 54 | kynurenine metabolic process (GO:0070189) | 3.18454899 |
| 55 | melanin biosynthetic process (GO:0042438) | 3.18238442 |
| 56 | UV protection (GO:0009650) | 3.17696993 |
| 57 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.16960644 |
| 58 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.16960644 |
| 59 | coenzyme catabolic process (GO:0009109) | 3.16900082 |
| 60 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.15889562 |
| 61 | creatine metabolic process (GO:0006600) | 3.14653757 |
| 62 | high-density lipoprotein particle remodeling (GO:0034375) | 3.14414249 |
| 63 | regulation of lipoprotein metabolic process (GO:0050746) | 3.14056161 |
| 64 | regulation of triglyceride catabolic process (GO:0010896) | 3.12912237 |
| 65 | cofactor catabolic process (GO:0051187) | 3.12888619 |
| 66 | plasma lipoprotein particle clearance (GO:0034381) | 3.11546812 |
| 67 | fatty acid beta-oxidation (GO:0006635) | 3.10955449 |
| 68 | negative regulation of cell size (GO:0045792) | 3.09815522 |
| 69 | cholesterol biosynthetic process (GO:0006695) | 3.09033239 |
| 70 | regulation of cholesterol esterification (GO:0010872) | 3.06466690 |
| 71 | indolalkylamine catabolic process (GO:0046218) | 3.04525700 |
| 72 | tryptophan catabolic process (GO:0006569) | 3.04525700 |
| 73 | indole-containing compound catabolic process (GO:0042436) | 3.04525700 |
| 74 | fatty acid catabolic process (GO:0009062) | 3.04331885 |
| 75 | thioester metabolic process (GO:0035383) | 3.02125379 |
| 76 | acyl-CoA metabolic process (GO:0006637) | 3.02125379 |
| 77 | nitrogen cycle metabolic process (GO:0071941) | 3.00889006 |
| 78 | cysteine metabolic process (GO:0006534) | 2.99567465 |
| 79 | lysine metabolic process (GO:0006553) | 2.97590826 |
| 80 | lysine catabolic process (GO:0006554) | 2.97590826 |
| 81 | purine ribonucleotide transport (GO:0015868) | 2.97191845 |
| 82 | regulation of cholesterol homeostasis (GO:2000188) | 2.94459859 |
| 83 | acetyl-CoA metabolic process (GO:0006084) | 2.93152050 |
| 84 | response to methylmercury (GO:0051597) | 2.92363047 |
| 85 | primary alcohol catabolic process (GO:0034310) | 2.91924892 |
| 86 | negative regulation of cholesterol transport (GO:0032375) | 2.90515157 |
| 87 | negative regulation of sterol transport (GO:0032372) | 2.90515157 |
| 88 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.90505194 |
| 89 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.90505194 |
| 90 | phospholipid efflux (GO:0033700) | 2.89940619 |
| 91 | protein insertion into membrane (GO:0051205) | 2.89663304 |
| 92 | protein-lipid complex assembly (GO:0065005) | 2.89205817 |
| 93 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.88143037 |
| 94 | fatty acid oxidation (GO:0019395) | 2.87855842 |
| 95 | aspartate family amino acid catabolic process (GO:0009068) | 2.87716542 |
| 96 | intestinal cholesterol absorption (GO:0030299) | 2.87139983 |
| 97 | negative regulation of fibrinolysis (GO:0051918) | 2.86969638 |
| 98 | cell-cell junction maintenance (GO:0045217) | 2.86498323 |
| 99 | monocarboxylic acid catabolic process (GO:0072329) | 2.85670944 |
| 100 | short-chain fatty acid metabolic process (GO:0046459) | 2.85332073 |
| 101 | lipid oxidation (GO:0034440) | 2.84972464 |
| 102 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.84489261 |
| 103 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.84127077 |
| 104 | barbed-end actin filament capping (GO:0051016) | 2.83407713 |
| 105 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.83277721 |
| 106 | protein carboxylation (GO:0018214) | 2.83277721 |
| 107 | response to mercury ion (GO:0046689) | 2.82425240 |
| 108 | bile acid metabolic process (GO:0008206) | 2.82275388 |
| 109 | tryptophan metabolic process (GO:0006568) | 2.82192050 |
| 110 | iron coordination entity transport (GO:1901678) | 2.81296865 |
| 111 | drug transmembrane transport (GO:0006855) | 2.79909195 |
| 112 | cellular ketone body metabolic process (GO:0046950) | 2.79224635 |
| 113 | mitotic nuclear envelope reassembly (GO:0007084) | 2.78817568 |
| 114 | nuclear envelope reassembly (GO:0031468) | 2.78817568 |
| 115 | melanin metabolic process (GO:0006582) | 2.77354442 |
| 116 | cholesterol homeostasis (GO:0042632) | 2.73020718 |
| 117 | amino-acid betaine metabolic process (GO:0006577) | 2.72795888 |
| 118 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.72350406 |
| 119 | plasma lipoprotein particle remodeling (GO:0034369) | 2.72284309 |
| 120 | protein-lipid complex remodeling (GO:0034368) | 2.72284309 |
| 121 | macromolecular complex remodeling (GO:0034367) | 2.72284309 |
| 122 | diacylglycerol metabolic process (GO:0046339) | 2.72150640 |
| 123 | adenine nucleotide transport (GO:0051503) | 2.72150481 |
| 124 | plasma lipoprotein particle assembly (GO:0034377) | 2.71766495 |
| 125 | tyrosine metabolic process (GO:0006570) | 2.71564791 |
| 126 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.71380633 |
| 127 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.71166357 |
| 128 | L-serine metabolic process (GO:0006563) | 2.70530970 |
| 129 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.70445038 |
| 130 | purine nucleotide transport (GO:0015865) | 2.70352745 |
| 131 | biotin metabolic process (GO:0006768) | 2.69871489 |
| 132 | sterol biosynthetic process (GO:0016126) | 2.69623431 |
| 133 | glucose catabolic process (GO:0006007) | 2.68905397 |
| 134 | cholesterol metabolic process (GO:0008203) | 2.68853399 |
| 135 | cellular modified amino acid catabolic process (GO:0042219) | 2.68848598 |
| 136 | opsonization (GO:0008228) | 2.68788815 |
| 137 | cholesterol efflux (GO:0033344) | 2.68538179 |
| 138 | apoptotic process involved in morphogenesis (GO:0060561) | 2.67044790 |
| 139 | peptidyl-proline hydroxylation (GO:0019511) | 2.65911512 |
| 140 | aromatic amino acid family metabolic process (GO:0009072) | 2.64911827 |
| 141 | valine metabolic process (GO:0006573) | 2.64882003 |
| 142 | sterol homeostasis (GO:0055092) | 2.64782436 |
| 143 | mitochondrial fusion (GO:0008053) | 2.64613492 |
| 144 | virion attachment to host cell (GO:0019062) | 2.64011902 |
| 145 | adhesion of symbiont to host cell (GO:0044650) | 2.64011902 |
| 146 | regulation of fibrinolysis (GO:0051917) | 2.63045778 |
| 147 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.63040361 |
| 148 | maternal placenta development (GO:0001893) | 2.62140629 |
| 149 | negative regulation of lipase activity (GO:0060192) | 2.61201889 |
| 150 | flavonoid metabolic process (GO:0009812) | 2.61000788 |
| 151 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.60298450 |
| 152 | aldehyde catabolic process (GO:0046185) | 2.60114693 |
| 153 | L-serine transport (GO:0015825) | 2.57862135 |
| 154 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.56972353 |
| 155 | serine transport (GO:0032329) | 2.55633946 |
| 156 | adherens junction assembly (GO:0034333) | 2.55247993 |
| 157 | positive regulation of nuclease activity (GO:0032075) | 2.53164146 |
| 158 | desmosome organization (GO:0002934) | 2.52966716 |
| 159 | pentose-phosphate shunt (GO:0006098) | 2.50301339 |
| 160 | glycolytic process (GO:0006096) | 2.50001703 |
| 161 | triglyceride biosynthetic process (GO:0019432) | 2.48112536 |
| 162 | protein hydroxylation (GO:0018126) | 2.43202350 |
| 163 | epithelial cell-cell adhesion (GO:0090136) | 2.42284008 |
| 164 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.42121310 |
| 165 | regulation of translational fidelity (GO:0006450) | 2.40970998 |
| 166 | adhesion of symbiont to host (GO:0044406) | 2.40282051 |
| 167 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.40006793 |
| 168 | secondary metabolite biosynthetic process (GO:0044550) | 2.38429320 |
| 169 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.37264914 |
| 170 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.36256150 |
| 171 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.35969350 |
| 172 | pinocytosis (GO:0006907) | 2.35942358 |
| 173 | acylglycerol catabolic process (GO:0046464) | 2.35688006 |
| 174 | neutral lipid catabolic process (GO:0046461) | 2.35688006 |
| 175 | fructose metabolic process (GO:0006000) | 2.35153581 |
| 176 | focal adhesion assembly (GO:0048041) | 2.34394710 |
| 177 | cell-substrate adherens junction assembly (GO:0007045) | 2.34394710 |
| 178 | peroxisome fission (GO:0016559) | 2.33853472 |
| 179 | tricarboxylic acid cycle (GO:0006099) | 2.33414081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.55139834 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.56257388 |
| 3 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.22422976 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.01481547 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.53705970 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.45650050 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.04247628 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.79634456 |
| 9 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.68143934 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.46945639 |
| 11 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.36725313 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.34883395 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.27782969 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.13851716 |
| 15 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.04451857 |
| 16 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.99008738 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.98358053 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.96909585 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.93549962 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.89187354 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.87365845 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.86677723 |
| 23 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.86478953 |
| 24 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.82136232 |
| 25 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78890419 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74690612 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.74100809 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.72723618 |
| 29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.72026394 |
| 30 | P68_20966046_ChIP-Seq_HELA_Human | 1.70240581 |
| 31 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.69036695 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68282670 |
| 33 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.64682808 |
| 34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.64665609 |
| 35 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.63281578 |
| 36 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61016621 |
| 37 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.59776586 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.57211540 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.56129885 |
| 40 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.54232248 |
| 41 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.53353842 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52848636 |
| 43 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.52525584 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52504683 |
| 45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.51407276 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49437818 |
| 47 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.49215675 |
| 48 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.49180940 |
| 49 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.45498632 |
| 50 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.45165062 |
| 51 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.42284426 |
| 52 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.41939225 |
| 53 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.41551229 |
| 54 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40909356 |
| 55 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.39174277 |
| 56 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.37382559 |
| 57 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37071528 |
| 58 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.37059499 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.36842090 |
| 60 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35078213 |
| 61 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.34976312 |
| 62 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.34431177 |
| 63 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34203345 |
| 64 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.34145775 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.34019179 |
| 66 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.33946929 |
| 67 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.33450151 |
| 68 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.32927872 |
| 69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32856382 |
| 70 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.32240943 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30879106 |
| 72 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30453737 |
| 73 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.30407885 |
| 74 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.30057710 |
| 75 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.29063287 |
| 76 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.27712298 |
| 77 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.26856288 |
| 78 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.26439996 |
| 79 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.25715148 |
| 80 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.25515619 |
| 81 | KDM2B_26808549_Chip-Seq_K562_Human | 1.24043540 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.24009712 |
| 83 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23633680 |
| 84 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.23229494 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23101048 |
| 86 | MYC_22102868_ChIP-Seq_BL_Human | 1.23068362 |
| 87 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.22501441 |
| 88 | MAF_26560356_Chip-Seq_TH1_Human | 1.21711415 |
| 89 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.21575589 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21389387 |
| 91 | * SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.20551277 |
| 92 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19938322 |
| 93 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.19085067 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18370171 |
| 95 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17604204 |
| 96 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.17451740 |
| 97 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16644877 |
| 98 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16290099 |
| 99 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15785532 |
| 100 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.15640328 |
| 101 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.15600999 |
| 102 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15484373 |
| 103 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.15176386 |
| 104 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.14604839 |
| 105 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.14567597 |
| 106 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14035140 |
| 107 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.13389576 |
| 108 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.13085541 |
| 109 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.13017491 |
| 110 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.12891904 |
| 111 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12531159 |
| 112 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12358101 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12179623 |
| 114 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.12108716 |
| 115 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.11968192 |
| 116 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11868338 |
| 117 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.11552266 |
| 118 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.10828530 |
| 119 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10151382 |
| 120 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.09335004 |
| 121 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.09296780 |
| 122 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.09040582 |
| 123 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08102290 |
| 124 | GATA2_19941826_ChIP-Seq_K562_Human | 1.07392658 |
| 125 | UTX_26944678_Chip-Seq_JUKART_Human | 1.06673042 |
| 126 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.06392956 |
| 127 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06038109 |
| 128 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.06021387 |
| 129 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03863152 |
| 130 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03612019 |
| 131 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.03320151 |
| 132 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02362363 |
| 133 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02250827 |
| 134 | MYB_26560356_Chip-Seq_TH2_Human | 1.00832844 |
| 135 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00332867 |
| 136 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98443172 |
| 137 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.98421789 |
| 138 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98411487 |
| 139 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98374033 |
| 140 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97627368 |
| 141 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97189516 |
| 142 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.96163063 |
| 143 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95702119 |
| 144 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94790513 |
| 145 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93069658 |
| 146 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92716381 |
| 147 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92609181 |
| 148 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92230806 |
| 149 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91743935 |
| 150 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91101796 |
| 151 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.91027214 |
| 152 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89738637 |
| 153 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.89142096 |
| 154 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88162084 |
| 155 | GATA1_22025678_ChIP-Seq_K562_Human | 0.87520316 |
| 156 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87410829 |
| 157 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.86945720 |
| 158 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.86254262 |
| 159 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86097796 |
| 160 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.85473381 |
| 161 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85389327 |
| 162 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84436103 |
| 163 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.84409699 |
| 164 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.83987324 |
| 165 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83906905 |
| 166 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.83022696 |
| 167 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.82140801 |
| 168 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.82140801 |
| 169 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.81832994 |
| 170 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.80083101 |
| 171 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.79883559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.64841866 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.34172484 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.95780942 |
| 4 | MP0009840_abnormal_foam_cell | 3.90393880 |
| 5 | MP0003011_delayed_dark_adaptation | 3.59355231 |
| 6 | MP0005365_abnormal_bile_salt | 3.34184382 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.15995598 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.05594159 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.89801737 |
| 10 | MP0005171_absent_coat_pigmentation | 2.86962360 |
| 11 | MP0005257_abnormal_intraocular_pressure | 2.76426293 |
| 12 | MP0005670_abnormal_white_adipose | 2.59864940 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.44636681 |
| 14 | MP0010030_abnormal_orbit_morphology | 2.37118085 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.31664770 |
| 16 | MP0005083_abnormal_biliary_tract | 2.31463092 |
| 17 | MP0000751_myopathy | 2.30406409 |
| 18 | MP0008260_abnormal_autophagy | 2.27498341 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.27343587 |
| 20 | MP0000003_abnormal_adipose_tissue | 2.24399069 |
| 21 | MP0003329_amyloid_beta_deposits | 2.21609576 |
| 22 | MP0004858_abnormal_nervous_system | 2.20282267 |
| 23 | MP0000920_abnormal_myelination | 2.16988906 |
| 24 | MP0003252_abnormal_bile_duct | 2.15673706 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.15593565 |
| 26 | MP0004272_abnormal_basement_membrane | 2.07952393 |
| 27 | MP0005332_abnormal_amino_acid | 1.92547016 |
| 28 | MP0000604_amyloidosis | 1.92032869 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.85251458 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.81693876 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.77340975 |
| 32 | MP0004147_increased_porphyrin_level | 1.69739658 |
| 33 | MP0000685_abnormal_immune_system | 1.67906030 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.65885502 |
| 35 | MP0003195_calcinosis | 1.64499332 |
| 36 | MP0001958_emphysema | 1.63896917 |
| 37 | MP0006082_CNS_inflammation | 1.62569660 |
| 38 | MP0003690_abnormal_glial_cell | 1.57838618 |
| 39 | MP0008438_abnormal_cutaneous_collagen | 1.57739004 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57462369 |
| 41 | MP0010234_abnormal_vibrissa_follicle | 1.53822370 |
| 42 | MP0003950_abnormal_plasma_membrane | 1.48703098 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.46720061 |
| 44 | MP0000609_abnormal_liver_physiology | 1.45830880 |
| 45 | MP0000537_abnormal_urethra_morphology | 1.44916415 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.42683634 |
| 47 | MP0005671_abnormal_response_to | 1.42408669 |
| 48 | MP0005409_darkened_coat_color | 1.41971189 |
| 49 | MP0004947_skin_inflammation | 1.40032234 |
| 50 | MP0009643_abnormal_urine_homeostasis | 1.39246877 |
| 51 | MP0002877_abnormal_melanocyte_morpholog | 1.39161252 |
| 52 | MP0009785_altered_susceptibility_to | 1.36228654 |
| 53 | MP0002970_abnormal_white_adipose | 1.30315101 |
| 54 | MP0002249_abnormal_larynx_morphology | 1.29748744 |
| 55 | MP0004264_abnormal_extraembryonic_tissu | 1.28979063 |
| 56 | MP0001661_extended_life_span | 1.28500704 |
| 57 | MP0003693_abnormal_embryo_hatching | 1.26773733 |
| 58 | MP0005076_abnormal_cell_differentiation | 1.25481341 |
| 59 | MP0002089_abnormal_postnatal_growth/wei | 1.25450940 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.25052642 |
| 61 | MP0005408_hypopigmentation | 1.24644418 |
| 62 | MP0009384_cardiac_valve_regurgitation | 1.22371547 |
| 63 | MP0001835_abnormal_antigen_presentation | 1.19860327 |
| 64 | MP0005451_abnormal_body_composition | 1.19765602 |
| 65 | MP0005025_abnormal_response_to | 1.19743048 |
| 66 | MP0003186_abnormal_redox_activity | 1.19262806 |
| 67 | MP0004782_abnormal_surfactant_physiolog | 1.17658985 |
| 68 | MP0003724_increased_susceptibility_to | 1.15943503 |
| 69 | MP0005464_abnormal_platelet_physiology | 1.14088835 |
| 70 | MP0003868_abnormal_feces_composition | 1.13576412 |
| 71 | MP0002933_joint_inflammation | 1.13172504 |
| 72 | MP0000566_synostosis | 1.13151335 |
| 73 | MP0000467_abnormal_esophagus_morphology | 1.12466027 |
| 74 | MP0003136_yellow_coat_color | 1.10965335 |
| 75 | MP0004381_abnormal_hair_follicle | 1.10181920 |
| 76 | MP0000462_abnormal_digestive_system | 1.09774557 |
| 77 | MP0008469_abnormal_protein_level | 1.08646297 |
| 78 | MP0005319_abnormal_enzyme/_coenzyme | 1.06594618 |
| 79 | MP0001764_abnormal_homeostasis | 1.05910333 |
| 80 | MP0001790_abnormal_immune_system | 1.05372742 |
| 81 | MP0005387_immune_system_phenotype | 1.05372742 |
| 82 | MP0004233_abnormal_muscle_weight | 1.04547391 |
| 83 | MP0003763_abnormal_thymus_physiology | 1.03674948 |
| 84 | MP0009672_abnormal_birth_weight | 1.02211529 |
| 85 | MP0000750_abnormal_muscle_regeneration | 1.00275501 |
| 86 | MP0006138_congestive_heart_failure | 0.99777651 |
| 87 | MP0010155_abnormal_intestine_physiology | 0.98518038 |
| 88 | MP0003111_abnormal_nucleus_morphology | 0.98319838 |
| 89 | MP0002796_impaired_skin_barrier | 0.97690560 |
| 90 | MP0003172_abnormal_lysosome_physiology | 0.97439704 |
| 91 | MP0000678_abnormal_parathyroid_gland | 0.97394448 |
| 92 | MP0000372_irregular_coat_pigmentation | 0.97142002 |
| 93 | MP0005666_abnormal_adipose_tissue | 0.96213984 |
| 94 | MP0002419_abnormal_innate_immunity | 0.94857278 |
| 95 | MP0009764_decreased_sensitivity_to | 0.94334143 |
| 96 | MP0001853_heart_inflammation | 0.94144245 |
| 97 | MP0003436_decreased_susceptibility_to | 0.93927919 |
| 98 | MP0000747_muscle_weakness | 0.93248265 |
| 99 | MP0003315_abnormal_perineum_morphology | 0.91841125 |
| 100 | MP0003634_abnormal_glial_cell | 0.89963002 |
| 101 | MP0005000_abnormal_immune_tolerance | 0.89634275 |
| 102 | MP0001800_abnormal_humoral_immune | 0.89311752 |
| 103 | MP0003866_abnormal_defecation | 0.89309532 |
| 104 | MP0003075_altered_response_to | 0.88717747 |
| 105 | MP0000465_gastrointestinal_hemorrhage | 0.87819000 |
| 106 | MP0002098_abnormal_vibrissa_morphology | 0.87675413 |
| 107 | MP0002971_abnormal_brown_adipose | 0.87220252 |
| 108 | MP0000681_abnormal_thyroid_gland | 0.86926575 |
| 109 | MP0006036_abnormal_mitochondrial_physio | 0.85939687 |
| 110 | MP0002723_abnormal_immune_serum | 0.85450918 |
| 111 | MP0003123_paternal_imprinting | 0.85372245 |
| 112 | MP0002075_abnormal_coat/hair_pigmentati | 0.85182325 |
| 113 | MP0005330_cardiomyopathy | 0.84901771 |
| 114 | MP0004130_abnormal_muscle_cell | 0.83994715 |
| 115 | MP0001243_abnormal_dermal_layer | 0.83330122 |
| 116 | MP0009763_increased_sensitivity_to | 0.83136537 |
| 117 | MP0001216_abnormal_epidermal_layer | 0.82032764 |
| 118 | MP0001845_abnormal_inflammatory_respons | 0.81629794 |
| 119 | MP0001348_abnormal_lacrimal_gland | 0.81034223 |
| 120 | MP0003279_aneurysm | 0.80691335 |
| 121 | MP0005508_abnormal_skeleton_morphology | 0.80476237 |
| 122 | MP0002420_abnormal_adaptive_immunity | 0.80439527 |
| 123 | MP0005636_abnormal_mineral_homeostasis | 0.79113094 |
| 124 | MP0001819_abnormal_immune_cell | 0.78519101 |
| 125 | MP0005501_abnormal_skin_physiology | 0.78325577 |
| 126 | MP0008932_abnormal_embryonic_tissue | 0.77797700 |
| 127 | MP0000598_abnormal_liver_morphology | 0.76611573 |
| 128 | MP0000015_abnormal_ear_pigmentation | 0.76407306 |
| 129 | MP0002452_abnormal_antigen_presenting | 0.76345838 |
| 130 | MP0001881_abnormal_mammary_gland | 0.75937568 |
| 131 | MP0000358_abnormal_cell_content/ | 0.75718052 |
| 132 | MP0005075_abnormal_melanosome_morpholog | 0.75456896 |
| 133 | MP0004087_abnormal_muscle_fiber | 0.74869395 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.74776345 |
| 135 | MP0010771_integument_phenotype | 0.74591483 |
| 136 | MP0001186_pigmentation_phenotype | 0.73751004 |
| 137 | MP0008004_abnormal_stomach_pH | 0.73432595 |
| 138 | MP0006054_spinal_hemorrhage | 0.72976880 |
| 139 | MP0000538_abnormal_urinary_bladder | 0.72797070 |
| 140 | MP0003879_abnormal_hair_cell | 0.72505421 |
| 141 | MP0001873_stomach_inflammation | 0.71925357 |
| 142 | MP0000371_diluted_coat_color | 0.71603957 |
| 143 | MP0002136_abnormal_kidney_physiology | 0.71451127 |
| 144 | MP0001730_embryonic_growth_arrest | 0.71334527 |
| 145 | MP0001851_eye_inflammation | 0.71108035 |
| 146 | MP0001533_abnormal_skeleton_physiology | 0.70828083 |
| 147 | MP0005375_adipose_tissue_phenotype | 0.70754619 |
| 148 | MP0000762_abnormal_tongue_morphology | 0.70142921 |
| 149 | MP0002148_abnormal_hypersensitivity_rea | 0.69862969 |
| 150 | MP0003453_abnormal_keratinocyte_physiol | 0.69622379 |
| 151 | MP0009931_abnormal_skin_appearance | 0.69397273 |
| 152 | MP0005334_abnormal_fat_pad | 0.69284008 |
| 153 | MP0001849_ear_inflammation | 0.67473174 |
| 154 | MP0009642_abnormal_blood_homeostasis | 0.67450655 |
| 155 | MP0005023_abnormal_wound_healing | 0.67333045 |
| 156 | MP0002822_catalepsy | 0.67023465 |
| 157 | MP0001765_abnormal_ion_homeostasis | 0.66808610 |
| 158 | MP0005165_increased_susceptibility_to | 0.65510221 |
| 159 | MP0000013_abnormal_adipose_tissue | 0.65211350 |
| 160 | MP0002060_abnormal_skin_morphology | 0.65055347 |
| 161 | MP0002254_reproductive_system_inflammat | 0.64601405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Xanthomatosis (HP:0000991) | 4.58718463 |
| 2 | Hyperlipoproteinemia (HP:0010980) | 4.26954163 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.25223474 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 3.91521919 |
| 5 | Vertebral compression fractures (HP:0002953) | 3.91145671 |
| 6 | Deep venous thrombosis (HP:0002625) | 3.78229907 |
| 7 | Hypoalphalipoproteinemia (HP:0003233) | 3.48026501 |
| 8 | Upper limb amyotrophy (HP:0009129) | 3.44537293 |
| 9 | Distal upper limb amyotrophy (HP:0007149) | 3.44537293 |
| 10 | Vascular calcification (HP:0004934) | 3.42137056 |
| 11 | Neurofibrillary tangles (HP:0002185) | 3.35882925 |
| 12 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32869889 |
| 13 | Protrusio acetabuli (HP:0003179) | 3.26448408 |
| 14 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.23218199 |
| 15 | Cardiovascular calcification (HP:0011915) | 3.16865817 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.15974746 |
| 17 | Hypolipoproteinemia (HP:0010981) | 3.14714195 |
| 18 | Hemorrhage of the eye (HP:0011885) | 3.01033910 |
| 19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.99219424 |
| 20 | Hypobetalipoproteinemia (HP:0003563) | 2.98667422 |
| 21 | Ulnar bowing (HP:0003031) | 2.91067208 |
| 22 | Ketosis (HP:0001946) | 2.88819329 |
| 23 | Ragged-red muscle fibers (HP:0003200) | 2.87287046 |
| 24 | Hyperacusis (HP:0010780) | 2.83149811 |
| 25 | Hand muscle atrophy (HP:0009130) | 2.82914713 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.75501737 |
| 27 | Hyperammonemia (HP:0001987) | 2.75296912 |
| 28 | Prolonged partial thromboplastin time (HP:0003645) | 2.70754527 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.70504911 |
| 30 | J-shaped sella turcica (HP:0002680) | 2.67038064 |
| 31 | Amyloidosis (HP:0011034) | 2.66873097 |
| 32 | Achilles tendon contracture (HP:0001771) | 2.65860922 |
| 33 | Hypoplasia of the thymus (HP:0000778) | 2.61695097 |
| 34 | Testicular atrophy (HP:0000029) | 2.60679652 |
| 35 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.59047536 |
| 36 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.59047536 |
| 37 | Distal lower limb muscle weakness (HP:0009053) | 2.58093470 |
| 38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.57333772 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 2.57333772 |
| 40 | Axonal loss (HP:0003447) | 2.56675324 |
| 41 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.49146183 |
| 42 | Abnormality of the Achilles tendon (HP:0005109) | 2.48543236 |
| 43 | Hyperglycinuria (HP:0003108) | 2.47508223 |
| 44 | Back pain (HP:0003418) | 2.46092884 |
| 45 | Growth hormone excess (HP:0000845) | 2.44524868 |
| 46 | Microvesicular hepatic steatosis (HP:0001414) | 2.42212912 |
| 47 | Cerebral inclusion bodies (HP:0100314) | 2.40472386 |
| 48 | Fat malabsorption (HP:0002630) | 2.39830164 |
| 49 | Biconcave vertebral bodies (HP:0004586) | 2.39679307 |
| 50 | Abnormality of glycolysis (HP:0004366) | 2.39392032 |
| 51 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.38341291 |
| 52 | Abnormality of methionine metabolism (HP:0010901) | 2.37389414 |
| 53 | T lymphocytopenia (HP:0005403) | 2.33808271 |
| 54 | Vacuolated lymphocytes (HP:0001922) | 2.30961973 |
| 55 | Prolonged neonatal jaundice (HP:0006579) | 2.30107272 |
| 56 | Distal lower limb amyotrophy (HP:0008944) | 2.29931361 |
| 57 | Ketoacidosis (HP:0001993) | 2.29669855 |
| 58 | Thin bony cortex (HP:0002753) | 2.27347288 |
| 59 | Mitral stenosis (HP:0001718) | 2.25810516 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 2.25766651 |
| 61 | Premature skin wrinkling (HP:0100678) | 2.25512676 |
| 62 | Broad distal phalanx of finger (HP:0009836) | 2.24387033 |
| 63 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.24347373 |
| 64 | Ileus (HP:0002595) | 2.23140664 |
| 65 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22053116 |
| 66 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22053116 |
| 67 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22053116 |
| 68 | Complement deficiency (HP:0004431) | 2.21309149 |
| 69 | Epidermoid cyst (HP:0200040) | 2.21300329 |
| 70 | Parakeratosis (HP:0001036) | 2.20842156 |
| 71 | Cervical subluxation (HP:0003308) | 2.18825849 |
| 72 | Cerebral aneurysm (HP:0004944) | 2.18159758 |
| 73 | Hypoglycemic coma (HP:0001325) | 2.17867659 |
| 74 | Systemic lupus erythematosus (HP:0002725) | 2.17856937 |
| 75 | Abnormal gallbladder physiology (HP:0012438) | 2.17713940 |
| 76 | Cholecystitis (HP:0001082) | 2.17713940 |
| 77 | Dysostosis multiplex (HP:0000943) | 2.16925163 |
| 78 | Cholelithiasis (HP:0001081) | 2.16359781 |
| 79 | Short nail (HP:0001799) | 2.14062558 |
| 80 | Abnormality of T cell number (HP:0011839) | 2.13469506 |
| 81 | Increased cerebral lipofuscin (HP:0011813) | 2.13330837 |
| 82 | Severe combined immunodeficiency (HP:0004430) | 2.13134363 |
| 83 | Hypercholesterolemia (HP:0003124) | 2.12821818 |
| 84 | Dicarboxylic aciduria (HP:0003215) | 2.12644032 |
| 85 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.12644032 |
| 86 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.12260802 |
| 87 | Peritonitis (HP:0002586) | 2.10633585 |
| 88 | Hyperbilirubinemia (HP:0002904) | 2.08062349 |
| 89 | Purpura (HP:0000979) | 2.07265663 |
| 90 | Generalized aminoaciduria (HP:0002909) | 2.06236843 |
| 91 | Abnormality of the common coagulation pathway (HP:0010990) | 2.05342721 |
| 92 | Abnormality of carpal bone ossification (HP:0006257) | 2.05019861 |
| 93 | Mesangial abnormality (HP:0001966) | 2.04636636 |
| 94 | Panhypogammaglobulinemia (HP:0003139) | 2.02149692 |
| 95 | Increased serum pyruvate (HP:0003542) | 2.01850498 |
| 96 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.00857160 |
| 97 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.00012341 |
| 98 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.00012341 |
| 99 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.00012341 |
| 100 | Stridor (HP:0010307) | 1.99946128 |
| 101 | Hyperparathyroidism (HP:0000843) | 1.98491784 |
| 102 | Abnormality of the corticospinal tract (HP:0002492) | 1.98033024 |
| 103 | Steatorrhea (HP:0002570) | 1.97995960 |
| 104 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.97809305 |
| 105 | Nuclear cataract (HP:0100018) | 1.97516931 |
| 106 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96338001 |
| 107 | Mucopolysacchariduria (HP:0008155) | 1.96338001 |
| 108 | Onion bulb formation (HP:0003383) | 1.95386609 |
| 109 | Acanthosis nigricans (HP:0000956) | 1.94765437 |
| 110 | Gingival bleeding (HP:0000225) | 1.94393077 |
| 111 | Rhabdomyolysis (HP:0003201) | 1.91054424 |
| 112 | Abnormality of purine metabolism (HP:0004352) | 1.90186542 |
| 113 | Joint hemorrhage (HP:0005261) | 1.90164744 |
| 114 | Hypokinesia (HP:0002375) | 1.90069025 |
| 115 | Turricephaly (HP:0000262) | 1.90016912 |
| 116 | Recurrent viral infections (HP:0004429) | 1.89755034 |
| 117 | Trismus (HP:0000211) | 1.89541588 |
| 118 | Increased connective tissue (HP:0009025) | 1.89397650 |
| 119 | Combined immunodeficiency (HP:0005387) | 1.88320895 |
| 120 | Abnormality of the umbilical cord (HP:0010881) | 1.87502994 |
| 121 | Myoglobinuria (HP:0002913) | 1.86575617 |
| 122 | Progressive neurologic deterioration (HP:0002344) | 1.86162991 |
| 123 | Flattened epiphyses (HP:0003071) | 1.86118874 |
| 124 | Hypoproteinemia (HP:0003075) | 1.85673626 |
| 125 | Abnormality of the thoracic spine (HP:0100711) | 1.85030495 |
| 126 | Long palpebral fissure (HP:0000637) | 1.84221888 |
| 127 | Opisthotonus (HP:0002179) | 1.83705120 |
| 128 | Progressive muscle weakness (HP:0003323) | 1.83162252 |
| 129 | Metabolic acidosis (HP:0001942) | 1.82270213 |
| 130 | Abnormality of dentin (HP:0010299) | 1.82062700 |
| 131 | Loss of speech (HP:0002371) | 1.81832505 |
| 132 | Generalized amyotrophy (HP:0003700) | 1.80768553 |
| 133 | Neonatal onset (HP:0003623) | 1.80752933 |
| 134 | Insomnia (HP:0100785) | 1.80592891 |
| 135 | Mitral regurgitation (HP:0001653) | 1.80467612 |
| 136 | Increased mean platelet volume (HP:0011877) | 1.80255792 |
| 137 | Hepatic necrosis (HP:0002605) | 1.79868131 |
| 138 | Abdominal distention (HP:0003270) | 1.79574859 |
| 139 | Spinal rigidity (HP:0003306) | 1.79555970 |
| 140 | Myopathic facies (HP:0002058) | 1.79141712 |
| 141 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.79041380 |
| 142 | Chronic otitis media (HP:0000389) | 1.78285431 |
| 143 | Hypertriglyceridemia (HP:0002155) | 1.76332656 |
| 144 | Exercise-induced myalgia (HP:0003738) | 1.76225695 |
| 145 | Lethargy (HP:0001254) | 1.75383093 |
| 146 | Abnormal platelet volume (HP:0011876) | 1.75343829 |
| 147 | Nonimmune hydrops fetalis (HP:0001790) | 1.75173269 |
| 148 | Abnormality of B cell number (HP:0010975) | 1.74640737 |
| 149 | B lymphocytopenia (HP:0010976) | 1.74640737 |
| 150 | Abnormality of proline metabolism (HP:0010907) | 1.74415739 |
| 151 | Hydroxyprolinuria (HP:0003080) | 1.74415739 |
| 152 | Athetosis (HP:0002305) | 1.73971555 |
| 153 | Nephritis (HP:0000123) | 1.71773499 |
| 154 | Malnutrition (HP:0004395) | 1.71174868 |
| 155 | Increased serum ferritin (HP:0003281) | 1.70761597 |
| 156 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.70605263 |
| 157 | Premature rupture of membranes (HP:0001788) | 1.70048494 |
| 158 | Abnormality of complement system (HP:0005339) | 1.69546326 |
| 159 | Shallow orbits (HP:0000586) | 1.69297050 |
| 160 | Fragile skin (HP:0001030) | 1.68761254 |
| 161 | Skin nodule (HP:0200036) | 1.68159812 |
| 162 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.67941766 |
| 163 | Absent epiphyses (HP:0010577) | 1.67941766 |
| 164 | Abnormal ossification of hand bones (HP:0005921) | 1.67880997 |
| 165 | Right ventricular cardiomyopathy (HP:0011663) | 1.67612896 |
| 166 | Vomiting (HP:0002013) | 1.66990659 |
| 167 | Flat acetabular roof (HP:0003180) | 1.66918316 |
| 168 | Increased muscle lipid content (HP:0009058) | 1.66424123 |
| 169 | Menorrhagia (HP:0000132) | 1.66390718 |
| 170 | Paraparesis (HP:0002385) | 1.66322901 |
| 171 | Cerebral edema (HP:0002181) | 1.66182810 |
| 172 | Elbow flexion contracture (HP:0002987) | 1.65875108 |
| 173 | Acanthocytosis (HP:0001927) | 1.65802313 |
| 174 | Myocardial infarction (HP:0001658) | 1.65459947 |
| 175 | Blue sclerae (HP:0000592) | 1.64921429 |
| 176 | Difficulty climbing stairs (HP:0003551) | 1.64835207 |
| 177 | Petechiae (HP:0000967) | 1.64417052 |
| 178 | Hepatosplenomegaly (HP:0001433) | 1.64177493 |
| 179 | Bulbar palsy (HP:0001283) | 1.61943554 |
| 180 | Spastic paraparesis (HP:0002313) | 1.60694079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 3.42627243 |
| 2 | ERN1 | 3.38846718 |
| 3 | EPHB1 | 3.27780461 |
| 4 | MST1R | 3.24705500 |
| 5 | BCKDK | 3.18711533 |
| 6 | SMG1 | 3.16827184 |
| 7 | STK39 | 2.84699506 |
| 8 | ICK | 2.59871939 |
| 9 | MET | 2.32442675 |
| 10 | PIM2 | 2.28867623 |
| 11 | IRAK3 | 2.24090903 |
| 12 | FGFR4 | 2.15485912 |
| 13 | OXSR1 | 1.92615917 |
| 14 | SIK1 | 1.91850598 |
| 15 | MAP4K1 | 1.91801462 |
| 16 | TRIB3 | 1.86061952 |
| 17 | MAPKAPK5 | 1.84182850 |
| 18 | TBK1 | 1.75003659 |
| 19 | TYK2 | 1.74784170 |
| 20 | PKN2 | 1.74395998 |
| 21 | ARAF | 1.71936761 |
| 22 | PIK3CA | 1.70647457 |
| 23 | PTK6 | 1.66039848 |
| 24 | VRK2 | 1.63742010 |
| 25 | PRPF4B | 1.63289270 |
| 26 | TESK2 | 1.61637340 |
| 27 | BUB1 | 1.59313036 |
| 28 | KDR | 1.59014115 |
| 29 | LRRK2 | 1.56692023 |
| 30 | NME2 | 1.53073700 |
| 31 | PAK4 | 1.49667507 |
| 32 | WNK4 | 1.47323435 |
| 33 | ITK | 1.40863987 |
| 34 | KIT | 1.39185326 |
| 35 | ZAP70 | 1.34632268 |
| 36 | TTN | 1.30024468 |
| 37 | TAOK2 | 1.27849050 |
| 38 | PRKD3 | 1.26618585 |
| 39 | ABL2 | 1.25763760 |
| 40 | CDK19 | 1.21621853 |
| 41 | TGFBR2 | 1.20458020 |
| 42 | MYLK | 1.19893421 |
| 43 | PTK2 | 1.19347841 |
| 44 | PDK2 | 1.17883950 |
| 45 | IKBKE | 1.16561890 |
| 46 | EPHB2 | 1.16526343 |
| 47 | CSF1R | 1.16503947 |
| 48 | LIMK1 | 1.14806136 |
| 49 | STK16 | 1.12250021 |
| 50 | RET | 1.11808309 |
| 51 | FGFR2 | 1.10573127 |
| 52 | MAP3K7 | 1.10270365 |
| 53 | PRKCQ | 1.09971322 |
| 54 | STK10 | 1.09046356 |
| 55 | BRAF | 1.08015397 |
| 56 | DDR2 | 1.08010078 |
| 57 | LMTK2 | 1.06675258 |
| 58 | FLT3 | 1.06602479 |
| 59 | BTK | 1.05873113 |
| 60 | WNK1 | 1.04871939 |
| 61 | MAP2K2 | 1.03203121 |
| 62 | LCK | 1.02777738 |
| 63 | GRK6 | 1.00129381 |
| 64 | SCYL2 | 0.96393431 |
| 65 | MST4 | 0.94161429 |
| 66 | TXK | 0.91506528 |
| 67 | AURKA | 0.91028867 |
| 68 | PDGFRA | 0.89686235 |
| 69 | BLK | 0.88388755 |
| 70 | DAPK3 | 0.87812347 |
| 71 | JAK1 | 0.87482066 |
| 72 | MAPK11 | 0.86874610 |
| 73 | EEF2K | 0.86169372 |
| 74 | MAP3K3 | 0.84878658 |
| 75 | MAP3K13 | 0.83228020 |
| 76 | PBK | 0.83114045 |
| 77 | CDK7 | 0.83102559 |
| 78 | RPS6KA2 | 0.81944713 |
| 79 | JAK3 | 0.80520078 |
| 80 | TNK2 | 0.79385537 |
| 81 | PHKG2 | 0.79318825 |
| 82 | PHKG1 | 0.79318825 |
| 83 | DYRK1B | 0.78631687 |
| 84 | MTOR | 0.78016914 |
| 85 | SYK | 0.77901787 |
| 86 | CSNK1G3 | 0.76750769 |
| 87 | MAPK12 | 0.76405390 |
| 88 | AKT2 | 0.75700632 |
| 89 | PRKD2 | 0.75444299 |
| 90 | ILK | 0.74371720 |
| 91 | DAPK1 | 0.74245215 |
| 92 | PDPK1 | 0.74007994 |
| 93 | HCK | 0.73683071 |
| 94 | CSNK1A1L | 0.72642026 |
| 95 | IRAK2 | 0.70922934 |
| 96 | TRPM7 | 0.70831650 |
| 97 | PRKD1 | 0.69024805 |
| 98 | CSK | 0.68418224 |
| 99 | PAK3 | 0.68104705 |
| 100 | BMX | 0.65586617 |
| 101 | MAPK4 | 0.65514292 |
| 102 | PDGFRB | 0.65170926 |
| 103 | PKN1 | 0.64448172 |
| 104 | PRKCI | 0.62087658 |
| 105 | TESK1 | 0.61046814 |
| 106 | TTK | 0.60837782 |
| 107 | PDK1 | 0.60753919 |
| 108 | FYN | 0.59490790 |
| 109 | CDC42BPA | 0.59346471 |
| 110 | MUSK | 0.58815135 |
| 111 | CDK15 | 0.58353467 |
| 112 | PRKCH | 0.58032450 |
| 113 | CDK11A | 0.57531067 |
| 114 | ROCK2 | 0.57128538 |
| 115 | INSRR | 0.56806501 |
| 116 | CSNK1G1 | 0.56522057 |
| 117 | CAMK2D | 0.56190981 |
| 118 | CAMK2G | 0.56088966 |
| 119 | JAK2 | 0.55822275 |
| 120 | MAP3K8 | 0.55113062 |
| 121 | LATS2 | 0.54040965 |
| 122 | MAP3K10 | 0.53670948 |
| 123 | PIK3CG | 0.53125715 |
| 124 | CDK18 | 0.52621668 |
| 125 | CDK14 | 0.51965587 |
| 126 | LYN | 0.50795034 |
| 127 | PAK1 | 0.50371687 |
| 128 | RPS6KB2 | 0.49658035 |
| 129 | NTRK1 | 0.49435423 |
| 130 | EPHA3 | 0.49394612 |
| 131 | RPS6KC1 | 0.49146391 |
| 132 | RPS6KL1 | 0.49146391 |
| 133 | SRC | 0.48865114 |
| 134 | RIPK1 | 0.47845613 |
| 135 | INSR | 0.47568775 |
| 136 | IRAK1 | 0.47062874 |
| 137 | TAOK3 | 0.46570028 |
| 138 | TNIK | 0.46005394 |
| 139 | CDK12 | 0.45622379 |
| 140 | PAK2 | 0.44589783 |
| 141 | PRKG2 | 0.44386312 |
| 142 | MAP2K3 | 0.44171529 |
| 143 | KSR2 | 0.43808297 |
| 144 | MAPKAPK3 | 0.43673134 |
| 145 | MARK2 | 0.42701525 |
| 146 | BRSK1 | 0.42158026 |
| 147 | MAP3K11 | 0.41688552 |
| 148 | CAMK2B | 0.40702263 |
| 149 | NLK | 0.39583821 |
| 150 | CDK6 | 0.38676793 |
| 151 | PRKAA1 | 0.34525136 |
| 152 | GSK3A | 0.33508010 |
| 153 | CCNB1 | 0.33331664 |
| 154 | TAOK1 | 0.32881840 |
| 155 | NME1 | 0.32037435 |
| 156 | STK38 | 0.31510836 |
| 157 | CDK4 | 0.31151817 |
| 158 | CSNK1G2 | 0.30972549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.57981458 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.44512144 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.62869060 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.56235728 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.47345551 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.43286310 |
| 7 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.41098457 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.39524933 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.37067301 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.35319179 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.31557438 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05417876 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.03530709 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.02725679 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.02492650 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.98858232 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.83422594 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.81082985 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80544055 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.76197071 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.75578632 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.65576234 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.61125451 |
| 24 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.59881693 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.57642408 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.48420177 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.48193439 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.47092498 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45894832 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.45752795 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.45567201 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.44752418 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43128906 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.42663264 |
| 35 | Base excision repair_Homo sapiens_hsa03410 | 1.36836799 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.36052042 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.35360866 |
| 38 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.32984982 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28428817 |
| 40 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.28307125 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 1.27005853 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26816730 |
| 43 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.21389305 |
| 44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.20725791 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.17940635 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.17204904 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.16177139 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12936689 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.12189211 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.11314449 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10249751 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09260948 |
| 53 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.07933282 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04473598 |
| 55 | Bladder cancer_Homo sapiens_hsa05219 | 1.02692975 |
| 56 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.00636811 |
| 57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.99092578 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98205106 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95732723 |
| 60 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.93682456 |
| 61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91591014 |
| 62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.90360535 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90277672 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.89981187 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89835297 |
| 66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.88669451 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.87034384 |
| 68 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.85579565 |
| 69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.83786752 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.83427505 |
| 71 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.81819676 |
| 72 | DNA replication_Homo sapiens_hsa03030 | 0.81111213 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.78024467 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76632197 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76455287 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76231556 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.75075288 |
| 78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73968665 |
| 79 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.72831682 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70385294 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.70041070 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.70026105 |
| 83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69509505 |
| 84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.69001942 |
| 85 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67418943 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60551120 |
| 87 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.58452123 |
| 88 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53868840 |
| 89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53427935 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53164676 |
| 91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51613647 |
| 92 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.51335515 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48628472 |
| 94 | Malaria_Homo sapiens_hsa05144 | 0.43179508 |
| 95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42529287 |
| 96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41815138 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.39828521 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39808096 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39666395 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36719548 |
| 101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36714150 |
| 102 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36560194 |
| 103 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.35437793 |
| 104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33554573 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33096079 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31272125 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29921755 |
| 108 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.29834086 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.29294134 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28270121 |
| 111 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.27408808 |
| 112 | Lysine degradation_Homo sapiens_hsa00310 | 0.26839021 |
| 113 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.25927714 |
| 114 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.24611830 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.24606225 |
| 116 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.24578038 |
| 117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.24069443 |
| 118 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.23916856 |
| 119 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.23339948 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.22757757 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.21947214 |
| 122 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.21460210 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | 0.20277356 |
| 124 | Parkinsons disease_Homo sapiens_hsa05012 | 0.19643824 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.18999859 |
| 126 | Pertussis_Homo sapiens_hsa05133 | 0.18849427 |
| 127 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.17222458 |
| 128 | Insulin resistance_Homo sapiens_hsa04931 | 0.17087602 |
| 129 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.16723789 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.15969466 |
| 131 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.14721643 |
| 132 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.14069365 |
| 133 | Alzheimers disease_Homo sapiens_hsa05010 | 0.13700337 |

